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Mesp2 is a bHLH-type transcription factor that plays a key role during somitogenesis. Mesp2 is transiently expressed and is quickly degraded
once translated. In our current study, we find that Mesp2 contains a degradation domain, which acts as a target of proteasome-mediated proteolysis
and appears to play this role in vivo. We have also defined the nuclear localization signals (NLS) and constructed a minimum Mesp2 protein
(P2-HD) composed of the NLS, bHLH and the degradation domains. The ability of the P2-HD as a transcription factor in vivo was examined.
Some of the defects that had been previously observed in the Mesp2-null mice were rescued in the knock-in mice but only in the posterior half
of the body, indicating differential effects of P2-HD along the anterior–posterior (AP) axis. In addition, quantitative analysis of the expression
along the AP axis revealed that the relative levels of Mesp2 increased, whereas Mesp1 is down-regulated in the later stages of development by
the activities of Mesp2 in the wild-type embryo. Moreover, we have found that somitogenesis in the early stages is more susceptible to changes
in the Mesp gene dosage, indicating that a threshold level of Mesp activity must be required for the progression of normal somitogenesis.
© 2006 Elsevier Inc. All rights reserved.Keywords: Mesp1; Mesp2; Somitogenesis; Vertebra; Protein degradation; Proteasome; Knock-in mouse; Nuclear localization; Basic helix–loop–helix;
Transcriptional factorIntroduction
Somitogenesis is a transient dynamic morphogenetic process
that generates somites in a rostro-caudal progression by
segmenting the paraxial mesoderm (Dubrulle and Pourquie,
2004). The somites provide basic axial structures that underlie
the segmental architecture of not only the vertebra, ribs and
muscles, which are all somite derivatives, but also of the
vascular and nervous systems (Brand-Saberi and Christ, 2000;
Monsoro-Burq and Le Douarin, 2000; Borycki and Emerson,
2000). The associated metamerism is regulated by periodic gene
expression, that functions as a so-called segmentation clock in
the presomitic mesoderm (PSM) in mouse (Aulehla and
Johnson, 1999; Aulehla and Herrmann, 2004; Aulehla et al.,
2003; Jouve et al., 2000; Bessho et al., 2001; Saga and Takeda,
2001; Giudicelli and Lewis, 2004). The periodicity is generated⁎ Corresponding author. Division of Mammalian Development, National
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doi:10.1016/j.ydbio.2006.08.043via a negative feed back loop of Notch signaling that activates
the transcription of Hes7, which is a negative regulator of itself,
and L-fng, which is a negative regulator of Notch signaling, and
this results in the oscillation of Notch activity (Bessho et al.,
2003; Rida et al., 2004). In addition, to achieve strict temporal
control of the clock, the stabilities of both the mRNA and pro-
teins have to be precisely regulated. Indeed, it has been shown
that the Hes7 protein is actively degraded via an ubiquitin–
proteasome pathway, which generates Hes7 protein oscillation
in the PSM. Furthermore, somitogenesis is disrupted by the in-
troduction of stabilized Hes7, in place of the wild-type protein.
In knock-in mice, the periodic gene expression of bothHes7 and
L-fng is destroyed, which is consistent with the notion that sta-
bility of these proteins has to be precisely regulated in addition
to their transcription and translation (Hirata et al., 2004).
We have been investigating the in vivo function of the bHLH
transcription factor, Mesp2, for which the periodic expression of
both mRNA and protein appears in the anterior PSM (Saga et al.,
1997).Mesp2defines the segmental border by suppressingNotch
signaling via the activation of L-fng and the suppression of Dll1
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also defines the rostral identity of the somites by suppressing the
expression of Dll1 and Uncx4.1, which is required for the
development of their caudal properties (Takahashi et al., 2003).
Thus, Mesp2 plays key roles in the anterior PSM, at the point of
transition of the paraxial mesodermal cells from the PSM to
somites. In addition, we have previously shown that Mesp1 is a
closely related member of theMesp family of genes, which share
significant sequencehomology in their bHLHregions (Sagaet al.,
1997). These genes are co-expressed in the early mesoderm, just
after gastrulation, and in the paraxial mesoderm during somito-
genesis. They also show a good degree of functional redundancy,
sinceaknock-inofMesp1 into theMesp2 locuscan rescuemostof
the defects that are observed in the Mesp2-null mouse (Saga,
1998). However, the functions of Mesp1 and Mesp2 during
somitogenesis are likely to be slightly different as chimeric
analyses have revealed that Mesp1 contributes to the epithelia-
lization of the somites but thatMesp2 is essential for establishing
rostro-caudal patterning (Takahashi et al., 2005).
In our current study, we have attempted to define the func-
tional domains of the Mesp2 protein by focusing on the verte-
bral development reflecting rostro-caudal properties of somites
in vivo. After determining both the degradation domain and the
nuclear localization signal of Mesp2, we constructed a possible
minimum functional Mesp2 protein containing the conserved
bHLH domain and assessed the ability of this truncated factor to
function in vivo by generating a Mesp2 locus knock-in of the
construct. The knock-in mice showed a hypomorphic phenotype
in which the defects are confined within the anterior half of
the axial skeleton. Comparative analyses of the expression of
the Mesp family genes subsequently revealed that the relative
levels of Mesp1 and Mesp2 change during somitogenesis,
and that a compensatory increase in Mesp1 may contribute to
rescue events in the posterior half of the axial skeleton.
Material and methods
Plasmid construction
Various constructs of Mesp2 were generated according to standard
molecular techniques. Deletion mutant constructs were created by PCR-
mediated methods, followed by ligation to native flanking DNA fragments. The
wild-type and deletion mutants were cloned into the p3xFLAG-CMV vector
(Sigma). EGFP-tagged Mesp2 variants were generated by inserting the Mesp2
coding sequence between EGFP and the poly-A signal.
Expression experiments using cultured cells
COS7 and NIH3T3 cells were maintained in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Cells were
transfected with 3xFLAG-Mesp2 wild-type or mutant constructs using FuGene
6 (Roche) according to the manufacturer's instructions. The cells were harvested
24 h after transfection and equal numbers of cells were replated with or without
cycloheximide (30 μg/ml) and with the protease inhibitors, MG132 (50 μM),
Z-Leu-Leu-Z (50 μM), PMSF (1 mM) or Pepstatin A (50 μM).
Immunoblotting of 3xFLAG-Mesp2 proteins in vivo
Western blot analysis was conducted using standard procedures. The PSM
region of five embryos of each genotype was collected from same litters atE10.5. The samples were lysed in buffer containing 50 mM Tris (pH 7.4), 0.2 M
NaCl, 1% Nonidet P40, 0.1% deoxycholate and a protease inhibitor cocktail
(Roche). The tissue extracts were separated by SDS-PAGE on 7.5% gels. The
3xFLAG-Mesp2 signals were detected by anti-FLAG antibody F3165 (Sigma)
and quantified using NIH Image. The signals were normalized to the expression
levels of β-actin which were detected by anti-β-actin antibody A2066 (Sigma).
Gene knock-in strategy
To generate several knock-in vectors for Mesp2 variants, we initially
constructed a targeting vector cassette with the gateway system (Invitrogen), in
which attL1 and attL2 were included in the site where the Mesp2-cDNAvariants
to be inserted. TheMesp2 cDNAs (P2-full, P2-ΔD, P2-HD) were subcloned into
the entry vectors for the gateway system and the final constructs were generated
by in vitro homologous recombination (Supplementary Fig. S1). Introduction of
the targeting vectors into ES cells (TT2) and subsequent screenings were
conducted as previously described (Yagi et al., 1993; Kitajima et al., 2000). The
chimeric mice were then crossed with ICR female mice to establish each mouse
line.
Histology, histochemistry and gene expression analysis
Section in situ hybridization and immunohistochemical detection of proteins
were performed as previously described (Morimoto et al., 2005). The methods
used for gene expression analysis by in situ hybridization of whole-mount
samples and skeletal staining have been described previously (Saga et al., 1997;
Takahashi et al., 2000).
Real-time PCR
Three primer pairs, one specific for Mesp1, one for Mesp2 and G3PDH,
were designed: Mesp1-L1 (5′-CCTTCGGAGGGAGTAGATC-3′) and Mesp1-
R1 (5′-AAAGCTTGTGCCTGCTTCA-3′); Mesp2-L2 (5′-GACTGGA-
CACTGGACACAATCCACT-3′) and Mesp2-R2 (5′-GGCCATAGCCAAG-
CAGACCTCAAA-3′); G3PDH-Fw (5′-ACCACAGTCCATGCCATCAC-3′)
and G3PDH-Rv (5′-TCCACCACCCTGTTGCTGTA-3′). The housekeeping
G3PDH gene was used as “reference” gene. PCR reactions were carried out in
48-well microtiter plate wells in a 20 μl reaction volume with SYBR premix Ex
Taq (TAKARA) with optimized concentrations of specific primers. An BIO-
RAD MiniOpticon Real Time PCR Detection System (BIO-RAD) was
programmed for an initial step of 10 s at 94°C, followed by 39 thermal cycles
of 15 s at 94°C, 15 s at 60°C, 30 s at 72°C. Every assay was run in triplicate and
negative controls (no template, template produced with no RT enzyme) were
always included. For each sample 1 μg of total RNAwas reverse transcribed. A
1:25 dilution of each cDNAwas used as template in real-time PCR. Specificity
of PCR amplification of each primer pair was confirmed by melting curve
analysis (Ririe et al., 1997). Standard curves were generated by measuring
threshold cycle (CT) values of ten-fold serial dilutions of the calibrator cDNAs
forMesp1 andMesp2. The relative transcript level was determined by a method
and formula as described (Pfaffl, 2001). To compare the level of Mesp1
expression in different genotypes, embryos were collected and pooled after
genotyping. Mesp1 expression level of each sample was normalized against
G3PDH. For the measurement of relative expression levels between Mesp1 and
Mesp2, three independent embryo samples were prepared from different stages
and the value of Mesp2 was normalized against Mesp1.Results
A mechanism to destabilize Mesp2 protein
A striking feature of the Mesp2 protein is its restricted
expression pattern in the anterior PSM every 2 h during
somitogenesis. Since the Mesp2 levels quickly dissipate once
the segmental border is established, we speculated that there
must be specific mechanisms that destabilize the protein. To
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stability of Flag-tagged Mesp2 protein, expressed in COS7
cells, with a number of protein inhibitors. Mesp2 protein is
detectable as several bands, due to phosphorylation by
endogenous kinases (Fig. 1 and Supplementary Fig. S2), and
appears to be stabilized in the presence of MG132 (proteasome
inhibitor), but not by Z-Leu-Leu-H, PMSF or Pepstatin A
(a calpain, serine protease or aspartic protease inhibitors,
respectively). To confirm this observation, a chase experiment
was conducted in the presence of cycloheximide, in which the
half life of Mesp2 protein was determined to be approximately
1.3 h in COS7 cells. The degradation rate, however, was
remarkably inhibited in the presence of MG132, whereby the
half life was extended to more than 4 h (Fig. 1B). These results
indicate that Mesp2 is mainly degraded by the proteasome
pathway, but also suggests the involvement of another
mechanism because the complete inhibition of Mesp2 degrada-
tion was not achieved by MG132 treatment (Fig. 1B).
To identify the Mesp2 domain required for its degradation, a
series of deletion mutants were individually expressed in COS7
cells and assayed for stability (Fig. 1C). A Δ311–330 mutant
was found to be the most stable in our assay system and
subsequent deletion analysis revealed that the region containing
amino acids 326–330 is the most likely to confer sensitivity to
the proteasome. We have thus designated this motif as the
“degradation domain”. To compare the effects of MG132 upon
full-length and mutant Mesp2 (Δ311–330) in cultured cells, the
protein levels were visualized by immunoblotting in the
presence of either MG132 or DMSO (Fig. 1D). The Δ311–
330 mutant protein was found to accumulate even in the
absence of MG132, indicating that it is stabilized by its
resistance to the proteasome pathway.
To confirm the destabilizing effect of the degradation domain
of Mesp2 in vivo, we generated knock-in mice expressing
FLAG-tagged -Mesp2 Δ326–330 (F-Mesp2ΔD) (Fig. 2A)
instead of the wild-type protein (Supplementary Fig. S2). As a
control, we also generated a knock-in mouse expressing FLAG-
tagged full-length-Mesp2 (F-Mesp2-full). The heterozygous
mice showed no abnormalities and the homozygous mice were
also fertile in the cases of both F-Mesp2ΔD and F-Mesp2-full.
To assess the stability of the introduced proteins, the
neighboring sections of the PSM region were subjected to in
situ hybridization analysis for Mesp2 transcripts and immuno-
histochemical detection of Mesp2 protein. We found that the
localization of the knock-in Mesp2 was similar to wild type
(Fig. 2B). Unexpectedly, however, the mRNA expression levels
of the introduced Mesp2s (both full-length and mutant) were
lower than wild type (Fig. 2B). Since Mesp2 expression levels
change cyclically during somitogenesis, we prepared several
repeat samples and confirmed this lower transcription result.
The reason for this effect is not clear but may be due to the
unrelated nucleotide sequences in the 5′-untranslated region of
the introduced by targeting vectors.
The level of protein expression was therefore also reduced in
the knock-in mouse embryos and we noticed a broad expression
domain for F-Mesp2ΔD. To determine the effects of a lack of
the Mesp2 degradation domain in vivo, the protein expressionlevels were compared by anti-FLAG Western blot analysis
using 5 tails from homozygous F-Mesp2ΔD and F-Mesp2-full
E10.5 embryos (Fig. 2C). The subsequent results indicated that
the F-Mesp2ΔD protein appears to be stabilized by the lack of a
degradation domain in vivo, since these protein levels are
relatively higher than F-Mesp2. In addition, comparative
analyses of the skeletal specimens at E17.5 suggest that the
degradation domain might be functional in vivo. The ho-
mozygous F-Mesp2-full mouse shows a fused rib pheno-
type at a high frequency (Fig. 2D). Interestingly, however, the
F-Mesp2ΔD fetus shows this rib defect at lower frequency.
We speculate that this situation may reflect the estimated
lower production of F-Mesp2-full under knock-in conditions
and that the defect is rescued by the stabilized F-Mesp2ΔD.
To further confirm this rescue effect, we reduced the gene
dosage by crossing F-Mesp2-full or F-Mesp2ΔD with
Mesp1/Mesp2 double KO (dKO) mice and compared the
skeletal phenotype in the presence of a single knock-in
allele. The homozygous dKO mice die before E9.5 due to
the lack of embryonic mesoderm (Kitajima et al., 2000) but
the heterozygous mouse has no abnormality in the skeletal
morphology (no rib fusion was detected among 6 fetuses
examined). F-Mesp2-full/dKO embryos showed more severe
abnormalities in the ribs and vertebra, with an average number
of fused ribs of 16, whereas the average number of fused ribs
was 6.5 in the F-Mesp2ΔD/dKO mice (Fig. 2D). These results
indicate that the stability of F-Mesp2 ΔD may positively affect
the function of Mesp2 and result in the suppression of the
defect caused by a lower dosage of Mesp alleles.
Generation of a minimum functional Mesp2 protein
Mesp2 localizes to the nucleus in a cell as a transcription
factor. To identify the minimum regions of Mesp2 that are
required for a functioning protein, we screened for a putative
nuclear localization signal (NLS) of Mesp2. Two arginine
clusters (R70,71,73 and R145–150) that could be implicated as
a potential NLS were identified outside of the basic helix–loop–
helix (bHLH) domain. We replaced these amino acids with
alanine residues and generated EGFP-tagged Mesp2 variants
(Supplementary Fig. S3A). The cellular localization of the
resulting Mesp2 proteins was then examined using confocal
microscopy (Supplementary Fig. S3B). Wild-type Mesp2-
EGFP was found to localize in the nucleus as expected, but
the R70,71,73A and R145–150A variants were observed not
only in the nucleus but also in the cytoplasm. Furthermore, the
R70,71,73,145–150Avariant was in fact mainly localized in the
cytoplasm. We confirmed that these GFP fusion proteins were
expressed as the correct size in the culture cells by the Western
blotting (Supplementary Fig. S3B). These data suggest that
R70,71,73 and R145–150 function as an NLS in the Mesp2
protein.
In addition to the degradation domain and the NLS, the
bHLH domain is known to be required for DNA binding
and for homo- or heterodimer formation. Hence, we tried to
construct a minimal but functional Mesp2 (P2-HD protein)
by combining the 3xFLAG tag with the regions 61–160aa
Fig. 1. The Mesp2 protein is degraded by the proteasome via its “degradation domain”. (A) Cos7 cells transfected with 3xFLAG-Mesp2 (F-Mesp2) were incubated in
the presence of cycloheximide and protease inhibitors, MG132, Z-L-L-H, PMSF or Pepstatin A for 2 h. The targets of these inhibitors are the proteasome, calpain,
serine proteases and aspartic proteases, respectively. The F-Mesp2 proteins were detected by immunoblotting with anti-FLAG antibodies. (B) F-Mesp2 protein
stability was analyzed in the presence of cycloheximide by treatment with either DMSO or MG132. The degradation process was then monitored by immunoblotting
with anti-FLAG antibodies and was found to be inhibited by MG132 but not DMSO (vehicle control). (C) Functional mapping of the degradation domain of Mesp2.
The degradation process was compared among the Mesp2 mutants shown in the figure by the same method used in panel B to identify the domains required for the
degradation of Mesp2. Stabilized mutants are indicated by the red circles on the right. (D) Either full-length or D311–330 mutant F-Mesp2 was transfected into Cos7
cells and cultivated for 6 h with or without MG132. F-Mesp2 proteins were then detected by Western blotting (left panel) and quantified using NIH Image software
(right panel).
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Mesp2 (Supplementary Fig. S3C). We confirmed that this
protein localized to the nucleus (Supplementary Fig. S3C).
To investigate the function of the P2-HD in vivo, we then
generated a P2-HD knock-in mouse using a similar method
to that described in Supplementary Fig. S1. P2-HD hetero-
zygous mice showed completely normal metameric vertebrae
at E17.5 (Fig. 3A upper). In contrast, the P2-HD homozy-
gous mice exhibited skeletal defects in the anterior region ofFig. 2. AMesp2 mutant protein that lacks the degradation domain is stabilized in vivo
ΔD). (B) Comparison of the Mesp2 expression levels (protein and mRNA) among
subjected to detection by either anti-Mesp2 antibodies or RNA probes. Among specim
(C) Western blot analysis of Mesp2 proteins in vivo. Sample lysates were prepared
Mesp2 proteins were then detected using anti-FLAG antibodies. Wild-type embryos
Mesp2 protein with anti-Mesp2 antibodies). The signal intensities were quantifie
Comparative analyses of skeletal defects among different Mesp genotypes. The skel
quantified by determining the number of fused sites. No fusions were detectable in t
mice at a higher frequency than in the homozygous F-Mesp2ΔD mice. A much m
Mesp2ΔD/dKO embryos due to the lower Mesp dosage.the vertebra along the A–P axis, the cervical and thoracic
vertebrae, and the rib (Fig. 3A middle). However, this pheno-
type was much milder than that of GFP-KI mice (Mesp2-null
mice), in which the pedicles of the neural arches in the entire
vertebra and the ribs are fused to each other as a result of the
caudalization of somites, as shown previously (Fig. 3A lower,
Takahashi et al., 2005). These data suggest that the P2-HD
protein partially rescues the skeletal defects observed in the
Mesp2-null mouse.. (A) Schematic representation of a 3xFLAG-Mesp2Δ326–330 mutant (F-Mesp2
wild-type (WT) Mesp2, F-Mesp2 and F-Mesp2ΔD. Neighboring sections were
ens examined, representative samples containing the highest signals are shown.
from five PSM tissues of WT, F-Mesp2 or F-Mesp2ΔD embryos at E11.0 and
served as a negative control (we have never successfully detected endogenous
d using NIH Image and normalized to the expression levels of β-actin. (D)
etal specimens were prepared at E17.5 and the defects observed in the rib were
he wild-type specimens. Fused ribs were detected in the homozygous F-Mesp2
ore severe skeletal phenotype was observed in both the F-Mesp2/dKO and F-
Fig. 3. The phenotype of a minimum Mesp2 functional mutant, P2-HD. (A–C) Comparative analyses of the skeletal morphologies at E17.5 (A) and the expression of
Uncx4.1 at E9.5 (B) in wild-type, P2-HD-KI or GFP-KI mice. (A) The homozygous P2-HD knock-in mouse exhibits skeletal defects in the anterior part of the axial
skeleton, the cervical and thoracic vertebra and in the rib (middle panels in A). Much stronger defects are observed in the GFP-KI (Mesp2-null) mouse. Red lines
indicate the skeletal defect region. (B) Metameric expression pattern of Uncx4.1 is disrupted in Mesp2-null embryo (right panel). This abnormal expression is rescued
in the homozygous P2-HD knock-in mouse (middle panel). (C) Mesp1 expression is increased in the P2-HD embryo at E10.5. The expression levels of the P2-HD
protein are lower than that of the wild-type (left panels). In contrast, the expression levels of Mesp1 were found to be up-regulated in the P2-HD KI embryo (middle
panels).
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(Mansouri et al., 1997), was observed in the caudal compart-
ments of the somites of both wild-type and P2-HD embryos,
whereas an extended expression pattern was observed in the
Mesp2-null embryo due to the lack of the rostral properties of
the somites (Fig. 3B). Therefore, judging by the expression
pattern of Uncx4.1, the minimal Mesp2 protein, P2-HD, can
substitute for Mesp2 in vivo. However, the expression of P2-
HD may not be sufficient to facilitate the gene regulation
required during subsequent vertebral development, particularly
in the anterior part of the axial skeleton. To determine the
mechanism underlying this region-specific defect, we firstFig. 4. The Mesp1 expression levels increase as somitogenesis progresses in P2-HD
probes using early (8 somites) to late (36 somites) somite-stage embryos. TheMesp1
somitogenesis. (B) The levels of Mesp1 expression were compared among wild-type
using samples derived from two litters at two different developmental stages (E8.5 and
time PCR analysis was then conducted for each genotype. The numbers of embryos us
mRNAwas normalized to G3PDH. (C) The relative ratio of the Mesp2 expression le
stages by real-time PCR with three different sets of cDNAs derived form wild-type
numbers of embryos used were indicated in the panel.analyzed Mesp2 expression using specific antibodies and found
that the levels of P2-HD protein are lower than wild type
(Fig. 3C). This phenomenon is consistent with our analyses of
F-Mesp2 and Mesp2ΔD KI mice, which showed lower ex-
pression of both protein and mRNA for these species. On the
other hand, using neighboring sections we have observed an up-
regulation of Mesp1 in the P2-HD homozygotes (Fig. 3C). In
the GFP-KI homozygous embryo, Mesp1 expression was also
enhanced (Supplementary Fig. S4A). Since we have found that
Mesp1 expression is enhanced, and that Mesp1 also plays an
important role in somitogenesis when the Mesp2 gene is de-
fective (Takahashi et al. manuscript in preparation), weKI mice. (A) Whole-mount in situ hybridization was performed with Mesp1
expression profile in the P2-HD KI embryo is stronger than wild type throughout
(+/+), P2HD heterozygous (+/HD) and P2HD homozygous (HD/HD) embryos
E9.75). Total RNA isolates were prepared from pooled whole embryos and real-
ed in the analyses varied from 2 to 5 as indicated in the panel. The level ofMesp1
vels to that of Mesp1 were examined at the early (E8.5) and later (E9.75) somite
embryos. These data were normalized to the levels of Mesp1 expression. The
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Mesp2 might be regulated during somitogenesis and the region-
specific defect that we observed in these experiments might
reflect such a functional bias.
Differential expression of Mesp1 and Mesp2 during
somitogenesis
Mesp1 and Mesp2 are transiently expressed prior to
segmental border formation. Therefore, the downstream target
genes must be involved in the subsequent chondrogenesis
pathways that are required for skeletal development (Takahashi
et al., 2000). Somites are sequentially generated from a rostral to
a caudal direction and it is known that their regional specificity
is defined when each somite is generated during development.
Cervical vertebra are derived from 5–12 somites generated
during E8.0–8.5, thoracic vertebrae are generated from 12–25
somites at E8.5–9.5, the lumbar are produced from 25–31
somites at E9.5–10.0, the sacral types are derived from 31–36
somites at E10.0–10.5 and caudal vertebrae are formed from
36–65 somites at E10.5–13.5 (Gossler and Tam, 2002).
To elucidate the contribution of Mesp1 to somitogenesis, and
the reason why the P2-HD proteins show region-specific defects
in the axial skeleton, the expression pattern of Mesp1 was
examined by whole-mount in situ hybridization from E8.5 (8–9
somites, cervical level) to E10.5 (35–36 somites, caudal
vertebral level) (Fig. 4A). In P2-HD homozygous embryos,
the expression level of Mesp1 was found to be higher than that
of the wild-type embryos throughout each of the stages
examined. In addition, it appears that the level of Mesp1
expression increases in the P2-HD embryo at the later stages,
whereas it was relatively constant in wild-type embryos. We
therefore reasoned that the normal vertebral formation from the
posterior to the lumbar levels is probably due to the up-
regulation of Mesp1 during somitogenesis. To confirm this
observation, we used quantitative RT-PCR to compare the levels
of Mesp1 during somitogenesis among wild-type and P2-HD
hetero- or homozygous littermates at E8.5 and E9.75 (Fig. 4B).
Since the embryo size differs from stage to stage, only the ratio
among different genotypes was compared. At E8.5, Mesp1
expression in P2-HD homozygous embryo was about 3.2-fold
higher than wild type. At E9.75, this higher level of Mesp1 wasFig. 5. Aworking hypothesis for the skeletal phenotypes of the Mesp2-mutants, depic
levels in the wild-type and mutant embryos, we speculate that the expression ofMesp
in tandem in the wild-type embryo. A reduction ofMesp2 function thus results in the
functional levels of Mesp1 and Mesp2 are maintained above a specific threshold (i
skeletal regions. (A) In the wild-type embryo, normal skeletal formation is maintained
these two proteins are above the required functional threshold throughout somitogen
andMesp2 is not sufficient to form the normal skeleton at the early stages of developm
a manner similar to wild-type Mesp2, and the resulting Mesp activity reaches the re
thereafter. The skeletal defects are then restricted to the anterior half of the body, inclu
single P2-HD allele, there is some delay in the Mesp levels reaching their functional th
lumber vertebral level. (D) Further reduction of the Mesp1 gene dosage compared
vertebrate. The collaborative activity of the Mesp gene reaches the required thres
functional threshold during somitogenesis and the skeletal defects extend to the most
mouse, which has only a singleMesp1 allele. The fetus thus shows severe truncation
suggest that the relative contributions of Mesp1 and Mesp2 differ during somitogenincreased to about 7.6 fold above wild type. As previously
reported, both Mesp1 and Mesp2 are expressed in the early
nascent mesoderm but the expression is transient and become
confined in the paraxial mesoderm after E8.25 just before
somitogenesis (Saga et al., 1999). These data indicate that the
differences in the expression levels ofMesp1 between wild-type
and P2-HD embryos increase with the progression of
somitogenesis.
Since Mesp1 and Mesp2 have some similar functions, and
the expression levels of both Mesp2 and Mesp1 are likely to be
important, we next analyzed the relative expression levels of
both genes using real-time PCR analysis with cDNAs from the
wild-type embryos. Because both the Mesp1 and Mesp2
expression patterns change cyclically at every somite formation,
we initially tested whether those expression patterns change
synchronously during somitogenesis. Bisected tail samples
were subjected to in situ hybridization using Mesp1 or Mesp2
probes. As shown in Supplementary Fig. S4B, the expression
levels of both signals do appear to change synchronously.
Consequently, we speculated that the relative RNA levels for
Mesp1 and Mesp2 could be analyzed using pooled RNA from
several embryo samples. Subsequently, the value of Mesp2 was
normalized to Mesp1 and we then compared the values during
somitogenesis. As anticipated by the cyclic expression pattern,
the value of Mesp1 and Mesp2 and the ratio between them
revealed by the real-time PCR were varied even in the same
developmental stage. However, we could confirm that the ratio
became increased as somitogenesis progresses. The mean
difference we have detected between E8.5 and E9.75 were
2.0-fold (Fig. 4C). These results suggest that the relative levels
of Mesp2 increase as somitogenesis proceeds, while the levels
of Mesp1 might be simultaneously reduced, in wild-type
embryos.
Functional contributions of Mesp1 and Mesp2 during
somitogenesis
Based on the above observations we hypothesized that (1)
Mesp2 suppresses Mesp1 expression in the later stage embryo,
(2) the reduction of Mesp2 results in the de-repression ofMesp1
and (3) a particular level of Mesp activity (Mesp1 + Mesp2) is
required for the normal progression of somitogenesis (Figs. 4ted in the right panels. By comparative analysis ofMesp1 andMesp2 expression
2 increases as somitogenesis progresses and that the levels ofMesp1 are reduced
de-repression ofMesp1 expression. Somitogenesis proceeds normally when the
ndicated by the dotted line in the right panels). Green lines indicate abnormal
by the collaborative expression and function ofMesp1 andMesp2. The levels of
esis. (B) In the P2-HD homozygous embryo, the collaborative activity of Mesp1
ent since the level of P2-HD is low. However, the P2-HD expression increases in
quired threshold at E9.5, which causes the restoration of normal somitogenesis
ding the cervical and thoracic vertebrae, and the ribs. (C) In the presence of only a
reshold (after E10.0), which results in the extension of the skeletal defects to the
with Mesp2 HD/GFP causes a further extension of the defect into the sacral
hold at E10.5. (E) In the Mesp2-null mouse, Mesp1 activity cannot reach the
posterior vertebra. (F) More severe defects are observed in theMesp2 GFP/dKO
of the vertebra that might be due to the atrophy of somite derivatives. These data
esis.
695M. Morimoto et al. / Developmental Biology 300 (2006) 687–698and 5A), and skeletal defects will thus only be observed in the
region where Mesp function is below this threshold level.
According to this hypothesis, the phenotype of P2-HD can be
interpreted as a lower Mesp activity (below the threshold) only
in the early stage embryo (Fig. 5B). Since we do not know the
definite values of Mesp1 and Mesp2 expression levels, we have
arbitrarily defined the threshold level for Mesp activity in thewild-type embryo as the activity required for establishing
normal rostro-caudal patterning, and we have assumed that only
the relative ratios of Mesp1 and Mesp2 change during
somitogenesis (Fig. 5A, right panel).
To evaluate our hypothesis, we genetically manipulated
somitogenesis by changing the dosage of Mesp1 and Mesp2
and examining the resulting skeletal morphologies at E17.5. By
696 M. Morimoto et al. / Developmental Biology 300 (2006) 687–698crossing P2-HD with either Mesp2 GFP or dKO mice we were
able to compare the Mesp1 dosage effects with the impact of a
single P2-HD allele (Figs. 5C and D). At first, we found that the
reduction of the P2-HD allele to a single dosage resulted in the
extension of the skeletal defects in the posterior part of the body,
which is visualized by the fusion of the pedicles of the neural
arches (Fig. 5C, left panel). The Mesp2 HD/dKO mouse, which
has both a single Mesp1 and P2-HD allele, showed a more
posterior expansion of this defect; both the fusion of the
pedicles and malformation of the caudal vertebra were evident
(Fig. 5D, left panel). Mesp2 GFP/GFF (Mesp2-null) mice
showed defects in their entire vertebra, and in this case we
predict that the levels of Mesp1 will not reach the threshold
level required for normal rostral–caudal patterning (Figs. 3B,
5E). The further reduction of Mesp1 levels in the Mesp2 GFP/
dKO mouse resulted in the shortening of the trunk region, as
well as more severe fusion of the vertebra (Fig. 5F). These
phenotypes can be explained for each genotype by our current
hypothesis (Fig. 5 right panel).
Discussion
Mesp2 protein stability is primarily regulated by a
proteasome-mediated pathway
The most notable feature of the Mesp2 expression profile is
the restriction of its expression domain in the anterior PSM,
with a clear boundary formed that will demarcate the next
segmental border (Morimoto et al., 2005). To establish the
segmental boundary, at intervals of 2 h in mice, the protein
would most likely need to be degraded once it achieves its
function. In our current experiments, a molecular mapping
study was successful in defining the “degradation domain” to
amino acids 326–330 of the Mesp2 protein, which is required
for proteolysis mediated by the proteasome in cultured cells
(Fig. 1). However, the proteasome inhibitor MG132 did not
completely abrogate Mesp2 proteolysis (Fig. 1B), indicating the
involvement of additional proteolytic pathways in this regula-
tion. We next attempted to determine the effects of this Mesp2
“degradation domain” in vivo by utilizing a knock-in strategy
for the stabilized construct into the endogenous locus (Fig. 2).
Unfortunately, however, this approach resulted in the reduction
in the levels of transcription and we observed relatively severe
defects in the control embryo into which a full-length Mesp2
fragment was introduced by a similar targeting strategy. These
defects could be ascribed to the lower levels of expression of
Mesp2 protein that are shown in Fig. 2B. In such a situation, a
more highly stable Mesp2 variant might compensate for the lack
of endogenous Mesp2 function. Thus we could not observe
anomalies that were due to a more highly stabilized Mesp
protein.
The P2-HD Mesp2 variant rescues the null defects in later
stage embryos
We constructed a truncated Mesp2 protein composed of the
NLS, bHLH and degradation domain, which we predictedwould be the minimum requirements for a functional protein
(Fig. S3C). The resulting knock-in mice displayed fused
pedicles of the neural arches in both the cervical and thoracic
regions (Fig. 3A), indicating that the somites were caudalized
during the early stages of somitogenesis at E8.0–9.5 due to the
lack of Mesp2 function. However, we could not detect any
abnormalities in the expression pattern of Uncx4.1, which is a
known downstream gene target of Mesp2 (Fig. 3B). This raised
the interesting issue of why the region-specific defects of P2-
HD occurred. The bHLH-type transcription factors are known
to work as homo- or heterodimers via the binding to target gene
enhancers. The targets may be selected by partnering factors
and the transcriptional activity might then be determined by
other interacting proteins recruited to the target sequences. In
this regard, we have recently shown that Mesp2 forms a
heterodimer with E47 and activates EphA4 transcription via the
binding of multiple E-boxes in the EphA4 enhancer (Nakajima
et al., 2006). It is possible that P2-HD may not have sufficient
ability to recruit other transcription factors required for full
activity. However, in the later stage embryo (after E9.5), the
deficiencies of the P2-HD protein might be compensated for by
increased levels of Mesp1, whereby Mesp function must reach a
sufficient level to fulfill its functional role. Since the targets of
Mesp2 that involved in pedicle formation have not yet been
identified, other than Uncx4.1, it is not yet feasible to analyze
the changes in the activity of these genes, the levels of which
would be expected to be low in the early stages but sufficiently
higher in the later stages of somitogenesis.
The gene dosage of Mesp1 and Mesp2 is critical for skeletal
development
The Mesp1 gene shows a similar expression pattern to
Mesp2 in the anterior PSM. In the Mesp2-null embryo, as well
as in other knock-in mice in which Mesp2 function is expected
to be reduced, the expression levels of Mesp1 increase,
indicating that Mesp2 generally suppressesMesp1 transcription.
We have now found that the level of Mesp2 expression
increases as somitogenesis progresses, and that Mesp1 expres-
sion consequently decreases during normal somitogenesis (Fig.
5A). In the P2-HD embryo, Mesp1 expression was found to
increase although it could not be determined whether this was
because of the lower levels of P2-HD expression in our current
knock-in strategy or due to the lesser ability of P2-HD to
suppress Mesp1 transcription. Unfortunately, we have no
antibody to detect Mesp1 protein. Nevertheless, we speculate
that P2-HD embryos can proceed with normal somitogenesis in
the later stages of development because of the rescue of Mesp
function by Mesp1 (Fig. 4). Since this compensatory phenom-
enon is mainly observed in later stage embryos, the dosage
effect is detected from the anterior part and then spreads to the
posterior region (Fig. 5).
The regulation of Mesp1 and Mesp2 during somitogenesis
Somitogenesis continues from stages E8.0 to E13.5 and the
basic regulatory mechanisms underlying somite segmentation
697M. Morimoto et al. / Developmental Biology 300 (2006) 687–698are most likely similar but may have some variation during this
process. It was recently shown in zebrafish that mutation of
integlinα5 affects only the early stages of somitogenesis,
although it is required for the maintenance of epithelial somites
(Julich et al., 2005a; Koshida et al., 2005). The reverse
phenomenon has been reported for mutants of Notch signaling
pathway genes. In both zebrafish (Holley et al., 2002; Julich et
al., 2005b) and mice (Conlon et al., 1995; Wong et al., 1997;
Zhang and Gridley, 1998; Bessho et al., 2001), Notch signaling
is involved in clock gene regulation and rostro-caudal
patterning (Rida et al., 2004). In either case, the defects in
Notch mutants become more severe as somitogenesis pro-
gresses. These data indicate that there could be some differences
in the regulatory mechanisms along the A–P axis. These
findings could also be explained by different contributions of
similar factors or by specific developmentally regulated
molecules. In the case of P2-HD homozygous mice, in which
the defects are observed only in the anterior part of the axial
skeleton (Figs. 3B and 5B), we do not think that the functions of
Mesp1 and Mesp2 change during somitogenesis. We instead
favor the idea that the levels of Mesp1 and Mesp2 change, and
that a critical balance is maintained, during somitogenesis in the
wild-type mouse.
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